Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4 Herbs Formula for Bone Metastases
NCT06023420Phase 2Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
Phase 2, randomised trial of Tuoli Xiaodu San in breast cancer (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Skeletal-related events at 3 months, General State at 3 months and 1 more. Status: unknown.
02
Drugs
Tuoli Xiaodu San
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06023420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06023420.